Arginine Market: RegionalAnalysis
On the basis of region, theglobal ArginineMarket is segmented into North America, Latin America, Europe, AsiaPacific, Middle East, and Africa.
Arginine, which is also known asL-arginine, is an essential amino acid for humans. Arginine is present in allprotein-containing foods such as grains, beans, nuts, meat, dairy products, andeggs, and it is also synthesized in the body from glutamine via citrulline aminoacid. Arginine plays an important role in cell division, wound healing, removalof ammonia from the body, boosting immune function, and in the release ofhormones.
Arginine Market: Drivers
Increasing researches on arginineas an adjuvant for the treatment of various diseases is expected to drivegrowth of the arginine market. For instance, an article published in PLOS Onejournal in May 2015 suggested that arginine might alter multi-species oralbiofilm development and may also break down dental plaque, which could helpmillions of people in preventing dental decay and gum diseases.
Furthermore, new productdevelopment is expected to fuel growth of the arginine market. For instance, inOctober 2018, Nutrition 21, LLC announced that its clinically substantiatedingredient, Nitrosigine, is now included in Elite Gold NX6 product.
* The sample copy includes: Report Summary, Table of Contents,Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2238
Elite Gold NX6 is a polymer ofarginine silicate, which is stabilized by inositol. Therefore, the developmentof Elite Gold NX6 with nitrosigine ingredient will help in boosting nitricoxide levels, which is found to be a key factor in generating greater bloodflow and vasodilation in working muscles.
Arginine Market: Restraint
Product recalls for arginine drugpackaging is expected to hamper growth of the arginine market. For instance, inNovember 2017, Therapeutics Goods Administration (TGA) of Australia recalledApotex Inc.’s Apo-Perindopril Arginine 2.5 mg, 5 mg, and 10 mg tablet batchesfrom the market due to contamination of tablet bottles with dark particles ofsilica. This contamination was classified as a quality defect. Apo-PerindoprilArginine is indicated for high blood pressure, heart failure or coronary arterydisease. Moreover, United Pharmacy recalled two lots of a compounded injectableglutamine/arginine/carnitine product, GAC-12 and GAC-13, in November 2017.
North America is projected toaccount for the largest share in the arginine market due to new productlaunches in the U.S. For instance, Pfanstiehl, Inc., a U.S.-based company, inSeptember 2018, launched a new high-purity, low-endotoxin, and low-metal,L-Arginine, which meets the U.S. Pharmacopoeia (USP), European Pharmacopoeia(EP), Japan Pharmacopoeia (JP), and Chinese Pharmacopoeia (ChP) standards. Thisis the first amino acid that Pfanstiehl, Inc. launched and manufactured in theU.S. under strict current good manufacturing practice (cGMP) and InternationalConference on Harmonization (ICH) Q7 compliant conditions.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/arginine-market-2238
Asia Pacific region is alsoexpected to witness significant growth in the arginine market, owing toexpansions of key players for the production of arginine formulations. Forinstance, in April 2018, CJ CheilJedang, a China-based firm, announced toexpand its L-Arginine and L-Citrulline production at its Jombang plant inIndonesia, which will be effective from 2019. By this expansion, the companyalso plans to manufacture its product, L-Citrulline (precursor of Arginine inbody), simultaneously in both China and Indonesia.
Arginine Market: CompetitiveLandscape
Key players operating in theglobal arginine market include Meihua Holdings Group Co., Ltd., Ajinomoto Co.,Inc., Jiahe Biological Technology Co., Ltd., Shijiazhuang Jirong PharmaceuticalCo., Ltd., Aminolabs, Atlantic Chemicals Trading GmbH, Glanbia Nutritionals,Wuxi Jinghai Amino Acid Co., Ltd., A & Z Food Additives Co., Ltd., GreenWave Ingredient, and Prinova Group LLC.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2238
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offering action-readysyndicated research reports, custom market analysis, consulting services, andcompetitive analysis through various recommendations related to emerging markettrends, technologies, and potential absolute dollar opportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
